Private company, CellTrans receives FDA approval for islet-cell therapy made from deceased-donors cells: https://www.fda.gov/news-events/press-announcements/fda-approves-first-cellular-therapy-treat-patients-type-1-diabetes The therapy, called Lantidra, is infused into the liver’s portal vein. The recipient must take immunosuppressive drugs.